Votucalis (Evolutec)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameVotucalis (Evolutec)
Drug Alias NameEV-131rEV-131
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionHistamine H4 receptor antagonists
TargetsHistamine H4 receptor
Therapy Area/IndicationsRhinitis, Allergic, Seasonal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEvolutec
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvolutec Group
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic, Seasonal

Other Information

ATC CodeN/A
Related LinksN/A